LEXX

LEXX

USD

Lexaria Bioscience Corp. Common Stock

$1.040-0.050 (-4.587%)

Real-time Price

Healthcare
Biotechnology
Canada

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.090

High

$1.100

Low

$0.934

Volume

0.07M

Company Fundamentals

Market Cap

20.3M

Industry

Biotechnology

Country

Canada

Trading Stats

Avg Volume

0.11M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.921Current $1.040High $4.38

Related News

AccessWire

Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule

Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events as compared to injected liraglutide ) Lexaria has now demonstrated, in distinct human clinical studies,

View more
Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule
AccessWire

Lexaria Attending BIO International Convention

Biotechnology Sector's Premier Strategic Partnering Event KELOWNA, BC / ACCESS Newswire / June 5, 2025 / Lexaria Bioscience Corp. , a global

View more
Lexaria Attending BIO International Convention